The Boston Globe - September 23, 2008

Anika signs Latin America marketing deal
The Boston Globe

Anika Therapeutics Inc. has signed an exclusive agreement under which DePuy Miteck Inc., a unit of Johnson & Johnson, will market its osteoarthritis treatments, Orthovisc and Orthovisc mini, throughout Latin America and the Caribbean. The deal gives the Bedford company "a strong foothold in a new and exciting market," CEO Charles H. Sherwood said. Analysts "have projected the osteoarthritis market in Latin America to grow at a rate of nearly 20 percent per year though 2016." Orthovisc is approved for knee injections in the United States and for use in all synovial joints in the European Economic Area.